Cognitive Assessment by the Mean of Event Related Potentials
NCT ID: NCT01899924
Last Updated: 2015-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
320 participants
INTERVENTIONAL
2013-07-31
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Function Assessment in Patients With Focal Brain Injury
NCT04182087
Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis
NCT01530438
Neurophysiological Study of Sensory and Cognitive Processes in Healthy Children and Adults
NCT03182400
Dysfunctions and Plasticity Mechanisms of Motor System Assessed by Cortico-cortical and Cortico-muscular Coherence Analysis in Amyotrophic Lateral Sclerosis
NCT01959373
Modeling Variation of the Objective Mental Workload for Tasks Requiring Different Cognitive Functions.
NCT05185102
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The procedure will be the following. After obtaining written informed consent, patients will be examined clinically with dedicated specialized scales (for example the CRS-R for disorders of consciousness patients). Then, we will probe event related potentials by stimulating these patients with various stimuli embedded in well-designed paradigms while their scalp EEG will be recorded. Following different steps of signal processing the mean ERPs according to conditions will be extracted and statistical analysis will be performed. At one year from the recording, outcome will be collected and correlated with the obtained ERPs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Event Related Potentials
Event Related Potentials recording
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Event Related Potentials recording
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent obtained from the subject,
* covers by social insurance,
* absence of psychoactive drug intake in the week preceding the examination or alcohol intake the day before the exam
* adults between 18 and 80,
* written informed consent obtained from the patient or his relatives,
* covers by social insurance,
* patients with either focal or diffuse brain damage drom trauma, vascular, tumor or other aetiologies, or with a history of neonatal or congenital diseases,
* patients with selective cognitive disorders or with altered states of consciousness
Exclusion Criteria
* sensory deficit incompatible with the participation in tne study,
* person under a legal protection measure, under guardianship,
* psychoactive drug intake in the week preceding the examination or alcohol intake the day before the exam
Patients :
* Pregnant patients or breastfeeding,
* sensory deficit incompatible with the participation in the study
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Limoges
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU of Limoges
Limoges, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I12011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.